If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

Share Price is delayed by 15 minutes
Get Live Data
33.50    0.00 (0.00%)
Bid:
32.00
Ask:
35.00
Spread: 3.00 (9.375%)
Market Cap: £3.08m
CPP Live PriceLast checked at - London Stock Exchange

Intraday Cppgroup Share Chart

Related Party Transaction

21 Jul 2022 07:00

RNS Number : 2039T
CPPGroup Plc
21 July 2022
 

21 July 2022

CPPGroup Plc

("CPP Group", the "Group" or the "Company")

Related Party Transaction

CPP Group (AIM: CPP), a provider of assistance and insurance products, which reduce disruptions to everyday life for millions of customers across the world, has entered into amended arrangements with the founders of Globiva Services Private Ltd ("Globiva").

The Group holds a 51% majority interest in Globiva, a Business Processes Management company incorporated in India, with the other 49% of the shares beneficially owned by the three founders of Globiva, Navneet Gupta, Vikram Singh Nathawat and Ashish Goyal, who continue to manage the business (the "Globiva Founders"). Globiva's results to 30 June 2022 are in line with expectations and ahead of prior year comparatives, with the business benefiting from improved trading conditions and notable new client wins.

 

Following an internal review and discussions with the Globiva Founders, the Board considers that the Shareholder Agreement ("SHA") signed in September 2018 included unrealistic commitments from the Group for the utilisation of Globiva's call-handling capacity; performance targets which it is now unable, and would never have been able, to satisfy. As a result, the Group has agreed to amend the SHA and certain other arrangements, as further set out below. 

 

CPP will provide additional funding of £0.5 million to Globiva through an existing repayable interest-bearing loan facility, which will be utilised to provide a one-time compensation payment to the Globiva Founders. Subsequently the balance on the repayable loan from the Company to Globiva will stand at circa £1.7 million, however, there are circumstances in which the Company may consent in the future to waive the amounts due.

 

The SHA further entitled, upon achievement of certain performance targets, the Globiva Founders to either a cash payment or to buyback 10% of the ordinary shares in Globiva from CPP Group, at the discretion of the Company. Under the amended arrangements, the Globiva Founders will, on meeting performance targets, buyback 10% of the ordinary shares in Globiva from CPP Group, however, in the normal course of business, it has been agreed this cannot be triggered until 1 January 2026 at the earliest.

 

The compensation payment to the Globiva Founders, who are also Directors of Globiva, along with the other arrangements described above, constitute a related party transaction under AIM Rule 13. The Directors of CPP Group consider, having consulted with the Company's nominated adviser, Liberum Capital Limited, that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

Simon Pyper, CEO of CPP Group, commented:

"The agreement we have reached with Globiva strengthens our relationship and provides a sound footing on which the business can continue to grow strongly and to the benefit of all parties." 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Enquiries:

CPP Group plc

Simon Pyper, Chief Executive Officer

via Alma PR

David Bowling, Chief Financial Officer

 

Liberum Capital Limited

(Nominated Adviser and Sole Broker)

Tel: +44 (0)20 3100 2000

Richard Lindley

Lauren Kettle

Alma PR

(Financial PR Adviser)

Tel: +44 (0)20 3405 0205

Josh Royston

David Ison

Kieran Breheny

 

About CPP Group:

CPP Group is a technology-driven assistance company that creates embedded and ancillary real-time assistance products and resolution services that reduce disruption to everyday life for millions of people across the world, at the time and place they are needed, CPP Group is listed on AIM, operated by the London Stock Exchange.

 

For more information on CPP visit https://international.cppgroup.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRZZGZNVGNGZZM
Date   Source Headline
30th Jun 20263:03 pmRNSResult of AGM
24th Jun 20265:35 pmRNSNotice of GM
5th Jun 20264:18 pmRNSPosting of Annual Report and Notice of AGM
5th Jun 20264:10 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSPRELIMINARY RESULTS YEAR ENDED 31 DECEMBER 2025
22nd Apr 20267:00 amRNSBLOCK LISTING 6 MONTHLY RETURN AND CANCELLATION
10th Apr 202612:34 pmRNSCompany Update
16th Mar 20267:00 amRNSCompany Update
16th Mar 20267:00 amRNSCompany Update
20th Jan 20267:00 amRNSBoard Appointment and Review of AIM Listing Status
7th Jan 20267:00 amRNSBlock listing Interim Review
9th Dec 20251:41 pmRNSHolding(s) in Company
5th Dec 20253:07 pmRNSTotal Voting Rights
21st Oct 20253:45 pmRNSBlock listing Interim Review
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20253:09 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHALF YEAR REPORT FOR SIX MONTHS ENDED 30 JUNE 2025
25th Sep 20257:12 amRNSCentral functions reorganisation & cost reductions
17th Sep 20259:13 amRNSCompletion of Disposal of CPP India
15th Sep 20257:00 amRNSUpdate regarding the Disposal of CPP India
2nd Sep 202510:34 amRNSChange of Registered Office
14th Aug 20251:28 pmRNSResult of General Meeting
29th Jul 20251:25 pmRNSPublication of Circular Notice of General Meeting
23rd Jul 20257:00 amRNSTransformation of CPP Group: Disposal of CPP India
4th Jul 20257:00 amRNSBlock listing Interim Review
24th Jun 20257:00 amRNSHolding(s) in Company
20th Jun 20257:00 amRNSHolding(s) in Company
18th Jun 20257:00 amRNSTransformation of CPP Group
30th May 20257:00 amRNSHolding(s) in Company
8th May 20257:00 amRNSResult of AGM
24th Apr 20257:00 amRNSBlock listing Interim Review
1st Apr 202511:21 amRNSPosting of Annual Report and Notice of AGM
25th Mar 20257:00 amRNSFULL YEAR RESULTS FOR YEAR ENDED 31 DECEMBER 2024
17th Jan 20257:00 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Update for Financial Year 2024
6th Jan 20257:00 amRNSBlock listing Interim Review
18th Nov 20247:00 amRNSDirectorate Change
22nd Oct 20247:00 amRNSBlock listing Interim Review
19th Sep 20247:00 amRNSHolding(s) in Company
17th Sep 20247:00 amRNSHalf-year Report for six months ended 30 June 2024
10th Sep 20247:00 amRNSAccelerated disposal of Globiva
6th Aug 20247:00 amRNSHolding(s) in Company
2nd Aug 20247:00 amRNSTotal Voting Rights
18th Jul 20247:00 amRNSTrading update for six months ended 30 June 2024
5th Jul 20247:00 amRNSBlock listing Interim Review
4th Jul 20247:00 amRNSDirector/PDMR Shareholding
2nd Jul 20247:00 amRNSHolding(s) in Company
2nd Jul 20247:00 amRNSExercise of Options and Director Shareholdings
1st Jul 20247:00 amRNSNominated Adviser and Broker
28th Jun 20247:00 amRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.